SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yi Sang

(Last)

(First)

(Middle)

C/O ZIMMER, INC.

P. O. BOX 708

(Street)

WARSAW

46580

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/24/2015

3. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZMH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Asia Pacific

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	647	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽¹⁾	03/18/2023	Common Stock	9,146	$73.15	D
Employee Stock Option (Right to Buy)	⁽²⁾	04/01/2023	Common Stock	5,325	$74.9	D
Employee Stock Option (Right to Buy)	⁽³⁾	03/17/2024	Common Stock	6,620	$94.34	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	800	⁽⁵⁾	D

Explanation of Responses:

1. 3,049 of the options vested on March 18, 2015; 3,049 of the options are scheduled to vest on March 18, 2016; and the remaining 3,048 of the options are scheduled to vest on March 18, 2017.

2. 1,775 of the options vested on April 1, 2015; 1,775 of the options are scheduled to vest on each of April 1, 2016 and 2017.

3. 1,655 of the options vested on March 17, 2015; 1,655 of the options are scheduled to vest on each of March 17, 2016, 2017 and 2018.

4. The restricted stock units ("RSUs") are scheduled to vest as follows: 400 vest on April 1, 2016 and 400 vest on April 1, 2017.

5. Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Heather J. Kidwell, Attorney-in-Fact for Sang Yi (power of attorney filed herewith)	06/26/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.